Typically, polyps are groups of abnormal cells that appear along mucous membranes in the body, though they can appear almost
Continue reading »
New treatment cures HALF of patients with untreatable skin cancer by
New treatment can cure HALF of patients with untreatable skin cancer by protecting the immune system from the deadly disease’s
Continue reading »
Precision medicine clinical trial releases new findings: NCI-MATCH data strengthen path forward for targeted cancer therapies
The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has
Continue reading »
Cancer drug keytruda a new weapon against advanced lung tumors
(HealthDay)—A cancer drug that boosts the immune system outperforms chemotherapy in fighting advanced lung cancer, a new trial shows. Keytruda
Continue reading »
New approach to immunotherapy leads to complete response in breast cancer patient
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression
Continue reading »
Is chemo for breast cancer overprescribed?
While new therapies such as immunotherapies are becoming increasingly crucial in treating cancer, chemotherapy is still a mainstay. In short,
Continue reading »
Study links neighborhood factors, breast cancer rates in African-American women
Neighborhood characteristics such as racial composition and poverty rates are associated with increased risks of late-stage breast cancer diagnoses and
Continue reading »
Breast cancer patients could be SPARED from gruelling chemotherapy
More than two thirds of breast cancer patients diagnosed each year could be SPARED from gruelling chemotherapy ordeal by taking
Continue reading »
Targeted cancer treatments far outperform traditional methods
Cancer treatments that attack tumors based on their individual genetic traits—not their location in the body—far outperform traditional methods, extending
Continue reading »
Trial shows how PET scans help tailor therapy for esophageal cancer
Survival results for the CALGB 80303 Trial presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018
Continue reading »